Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population
Clinical trial NCT00137033 · COMPLETED
Trial details
- NCT number
- NCT00137033
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Enrollment
- 605
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.